Cargando…
Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395435/ https://www.ncbi.nlm.nih.gov/pubmed/25876069 http://dx.doi.org/10.1371/journal.pone.0124893 |
_version_ | 1782366449609736192 |
---|---|
author | Jennings, Barbara A. Loke, Yoon K. Skinner, Jane Keane, Melanie Chu, Gavin S. Turner, Richard Epurescu, Daniel Barrett, Ann Willis, Gavin |
author_facet | Jennings, Barbara A. Loke, Yoon K. Skinner, Jane Keane, Melanie Chu, Gavin S. Turner, Richard Epurescu, Daniel Barrett, Ann Willis, Gavin |
author_sort | Jennings, Barbara A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4395435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43954352015-04-21 Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines Jennings, Barbara A. Loke, Yoon K. Skinner, Jane Keane, Melanie Chu, Gavin S. Turner, Richard Epurescu, Daniel Barrett, Ann Willis, Gavin PLoS One Correction Public Library of Science 2015-04-13 /pmc/articles/PMC4395435/ /pubmed/25876069 http://dx.doi.org/10.1371/journal.pone.0124893 Text en © 2015 Jennings et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Correction Jennings, Barbara A. Loke, Yoon K. Skinner, Jane Keane, Melanie Chu, Gavin S. Turner, Richard Epurescu, Daniel Barrett, Ann Willis, Gavin Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title | Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title_full | Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title_fullStr | Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title_full_unstemmed | Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title_short | Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines |
title_sort | correction: evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395435/ https://www.ncbi.nlm.nih.gov/pubmed/25876069 http://dx.doi.org/10.1371/journal.pone.0124893 |
work_keys_str_mv | AT jenningsbarbaraa correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT lokeyoonk correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT skinnerjane correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT keanemelanie correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT chugavins correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT turnerrichard correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT epurescudaniel correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT barrettann correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines AT willisgavin correctionevaluatingpredictivepharmacogeneticsignaturesofadverseeventsincolorectalcancerpatientstreatedwithfluoropyrimidines |